info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Interventional Cardiology Companies

Interventional cardiology companies play a crucial role in developing and providing medical devices and technologies for diagnosing and treating cardiovascular diseases through minimally invasive procedures. These procedures typically involve catheter-based techniques and imaging guidance to access and treat the heart and blood vessels.

Interventional Cardiology Key CompaniesLatest Interventional Cardiology Companies Update

May 2023: Robocath, a corporation specializing in the design, development, and commercialization of intelligent robotic solutions for cardiovascular disease treatment, has recently introduced the R-One+, its most recent robotic platform. Interventional cardiologists are able to conduct coronary angioplasties with the R-One+ robotic solution by utilizing an integrated control command unit situated in the control room or cath lab to operate the devices. This establishes two primary advantages: initially, it safeguards the cardiologist and the medical staff against radiation-induced harm; and secondly, it simplifies and improves the safety of the PCI procedure. Cardiologists are able to execute improved hand gestures with heightened accuracy and under more comfortable working conditions, all of which are advantageous for the patient, owing to the utilization of R-One+.


September 2023: Avinger, Inc., a medical device company in the commercial stage that markets the first and only catheter-based intravascular image-guided system for the diagnosis and treatment of vascular disease, has today announced the Tigereye; ST next generation image-guided chronic total occlusion (CTO) crossing system into full commercial availability. As of the commencement of the overall commercial launch, the Tigereye ST device is now available for purchase by all existing and potential clients. Prior to complete commercialization, Avinger conducted a limited launch of Tigereye ST at eleven clinical centers in the United States, during which thirteen clinicians performed approximately fifty CTO procedures. The preliminary cases underscored the effective integration of the novel design elements into the platform, in addition to an outstanding safety record, proficiency in traversing exceptionally difficult lesions, and remarkable product dependability.List of Interventional Cardiology Key companies in the market

  • ABIOMED (US)

  • Abbott (US)

  • ACIST Medical Systems, Inc. (US)

  • Braun Melsungen AG (Germany)

  • BD (US)

  • Biosense Webster, Inc (US)

  • Biotronik SE & Co. KG (Germany)

  • Boston Scientific Corporation (US)

  • Cardinal Health (US)

  • Cook Medical (US)

  • Edwards Lifesciences Corporation (US)

  • GE Healthcare (US)

  • Koninklijke Philips N.V. (Netherlands)

  • Life Vascular Devices Biotech S.L. (Spain)

  • Medtronic (Ireland)

  • Merit Medical Systems, Inc (US)

  • Terumo Corporation (Japan)

  • L. Gore & Associates, Inc. (US)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.